Trial Search Results

68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer

This clinical trial studies gallium-68 (68Ga)-prostate specific membrane antigen (PSMA) (gallium Ga 68-labeled PSMA ligand Glu-urea-Lys[Ahx]) positron emission tomography (PET)/computed tomography (CT) or PET/magnetic resonance imaging (MRI) in identifying prostate cancer that may have returned after a period of improvement (biochemical recurrence). 68Ga-PSMA is a radiopharmaceutical that localizes to a specific prostate cancer receptor, which can then be imaged by the PET/CT or PET/MRI scanner.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Cancer Institute (NCI)

Intervention(s):

  • Procedure: Computed Tomography
  • Drug: Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx)
  • Procedure: Magnetic Resonance Imaging
  • Procedure: Positron Emission Tomography

Phase:

Phase 1/Phase 2

Eligibility


Inclusion Criteria:

   - Provides written informed consent

   - Known diagnosis of prostate cancer

   - Patient has suspected recurrence based on biochemical data (prostate specific antigen
   [PSA] > 2 ng/mL)

   - Able to remain still for duration of each imaging procedure (about one hour)

Exclusion Criteria:

   - Unable to provide informed consent

   - Inability to lie still for the entire imaging time

   - Inability to complete the needed investigational and standard-of-care imaging
   examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)

   - Any additional medical condition, serious intercurrent illness, or other extenuating
   circumstance that, in the opinion of the Investigator, may significantly interfere
   with study compliance

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Male

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
ccto-office@stanford.edu
650-498-7061
Not Recruiting